Nurix Therapeutics discloses minimal SVB exposure; less than 1% of cash at SVB

Nurix Therapeutics, Inc.

SVB closed by California DFPI on March 10; FDIC appointed receiver.
U.S. Treasury, Fed, FDIC: all depositors fully protected; funds accessible March 13.
Nurix's SVB account holds less than 1% of total cash, equivalents, and marketable securities.
Remaining cash held at other large, global financial institutions.
Company believes exposure is immaterial and funds will be fully available.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.